第一单位：
Department of Neuropathology, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany.;German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Berlin, Germany.
作者：
Kiara,Freitag [1]
;
Nele,Sterczyk [2]
;
Sarah,Wendlinger [3]
;
Benedikt,Obermayer [4]
;
Julia,Schulz [2]
;
Vadim,Farztdinov [5]
;
Michael,Mülleder [5]
;
Markus,Ralser [6]
;
Judith,Houtman [2]
;
Lara,Fleck [2]
;
Caroline,Braeuning [7]
;
Roberto,Sansevrino [8]
;
Christian,Hoffmann [8]
;
Dragomir,Milovanovic [8]
;
Stephan J,Sigrist [9]
;
Thomas,Conrad [7]
;
Dieter,Beule [4]
;
Frank L,Heppner [10]
;
Marina,Jendrach [11]
作者单位：
Department of Neuropathology, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany.;German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Berlin, Germany.
[1]
Department of Neuropathology, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany.
[2]
Department of Neuropathology, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany.;Department of Biosciences, University of Salzburg, Salzburg, Austria.
[3]
Core Unit Bioinformatics, Berlin Institute of Health at Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.
[4]
Core Facility, High-Throughput Mass Spectrometry, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
[5]
Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.;Department of Biochemistry, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
[6]
Genomics Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.;Berlin Institute of Health (BIH), Berlin, Germany.
[7]
Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Berlin, Germany.
[8]
German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Berlin, Germany.;Cluster of Excellence, NeuroCure, Berlin, Germany.;Institute for Biology and Genetics, Freie Universität Berlin, Berlin, Germany.
[9]
Department of Neuropathology, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany.;German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Berlin, Germany.;Cluster of Excellence, NeuroCure, Berlin, Germany.
[10]
Department of Neuropathology, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany. marina.jendrach@charite.de.
[11]
DOI
10.1186/s12974-022-02534-7
PMID
35780157
发布时间
2022-07-20
换一批
